P02.59. Complexity of Disease and Population Heterogeneity Require a Rethinking of Clinical Trial Design

BMC Complementary and Alternative Medicine - United Kingdom
doi 10.1186/1472-6882-12-s1-p115
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clinical Heterogeneity in Fabry Disease

Nervno-Myshechnye Bolezni
Neurology
2015English

A Pragmatic, Adaptive Clinical Trial Design for a Rare Disease: The FOcal Cerebral Arteriopathy Steroid (FOCAS) Trial

Contemporary Clinical Trials
MedicinePharmacology
2019English

Clinical Heterogeneity of Recessive Ataxia in the Mexican Population

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2006English

Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease

American Journal of Nephrology
Nephrology
2017English

Heterogeneity in Recent-Onset Type 1 Diabetes - A Clinical Trial Perspective

Diabetes/Metabolism Research and Reviews
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Value of Information Methods to Design a Clinical Trial in a Small Population to Optimise a Health Economic Utility Function

BMC Medical Research Methodology
EpidemiologyHealth Informatics
2018English

Testing for Heterogeneity Among the Components of a Binary Composite Outcome in a Clinical Trial

BMC Medical Research Methodology
EpidemiologyHealth Informatics
2010English

Rethinking Impact: Understanding the Complexity of Poverty and Change – Overview

Development in Practice
DevelopmentPlanningGeography
2010English

Rethinking Clinical Trials

Science
MultidisciplinaryPhilosophy of ScienceHistory
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy